Josh Autaubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Josh Autaubo has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Matt Vassar
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
3 shared publications - Alicia Ito Ford
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
2 shared publications - Andrew Wilson
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
2 shared publications - Merhawit Ghebrehiwet
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
2 shared publications - Payton Clark
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
2 shared publications Andee Beth Fitts
Office of Medical Student Research (Mr. Autaubo, Ms. Fitts, Ms. Wise, Ms. Flores, Mr. Kee, Ms. Garrett, Mr. Rucker, and Dr. Vassar), Tulsa, Oklahoma
1 shared publication
Latest Publications
- Open Access
- 29 April 2025
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 9 (5)
Recruitment and Retention Strategies in Clinical Trials for Hip Fractures: A Cross-Sectional Analysis
Objective: To investigate the recruitment and retention strategies in clinical trials evaluating hip fractures, with a focus on underrepresented populations. Background: The prevalence and burden of hip fractures necessitate diverse and representative clinical trials to improve management outcomes. Underrepresented populations often face barriers to participation, affecting the generalizability of trial results. Methods: We conducted a cross-sectional analysis of clinical trials on hip fractures published between 2018 and 2023. We searched Embase and MEDLINE, screening and extracting data in a masked duplicate manner. For statistical analysis, Stata 18 SE (StataCorp LLC) was used to determine frequencies of recruitment and retention strategies. Results: We screened 624 studies, with 72 meeting our inclusion criteria. Trials were conducted in the United States (12/72, 16.7%), non-United States (53/72, 73.6%), or both (7/72, 9.7%). Only one trial (1.4%) mentioned specific recruitment strategies, and three (4.2%) reported measures to minimize participant dropout. Overall, the mention of strategies for diverse participation was scarce. Conclusion: There is a notable lack of recruitment and retention strategies directed at promoting diverse participation in hip fracture trials. This study highlights the need for improved inclusiveness and equity in future clinical trials to enhance the generalizability of their findings and better serve all populations affected by hip fractures.
- 29 April 2025
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 9 (5)
Open AccessRecruitment and Retention Strategies in Clinical Trials for Hip Fractures: A Cross-Sectional Analysis
Objective: To investigate the recruitment and retention strategies in clinical trials evaluating hip fractures, with a focus on underrepresented populations. Background: The prevalence and burden of hip fractures necessitate diverse and representative clinical trials to improve management outcomes. Underrepresented populations often face barriers to participation, affecting the generalizability of trial results. Methods: We conducted a cross-sectional analysis of clinical trials on hip fractures published between 2018 and 2023. We searched Embase and MEDLINE, screening and extracting data in a masked duplicate manner. For statistical analysis, Stata 18 SE (StataCorp LLC) was used to determine frequencies of recruitment and retention strategies. Results: We screened 624 studies, with 72 meeting our inclusion criteria. Trials were conducted in the United States (12/72, 16.7%), non-United States (53/72, 73.6%), or both (7/72, 9.7%). Only one trial (1.4%) mentioned specific recruitment strategies, and three (4.2%) reported measures to minimize participant dropout. Overall, the mention of strategies for diverse participation was scarce. Conclusion: There is a notable lack of recruitment and retention strategies directed at promoting diverse participation in hip fracture trials. This study highlights the need for improved inclusiveness and equity in future clinical trials to enhance the generalizability of their findings and better serve all populations affected by hip fractures.
- Open Access
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Examining Recruitment and Retention Strategies in Hidradenitis Suppurativa Clinical Trials: A Cross‐Sectional Study
Background: To ensure equitable and successful treatment outcomes for hidradenitis suppurativa (HS), the recruitment and retention of diverse participants in clinical trials is critical. However, current approaches may neglect under‐represented populations, potentially limiting the result application. Objective: This study aimed to evaluate existing recruitment and retention strategies in HS trials, identifying gaps and proposing methods to improve inclusivity and participant retention. Methods: We conducted a cross‐sectional analysis of 36 HS clinical trials from January 2018 to December 2023, following PRISMA guidelines. Trial characteristics and specific recruitment/retention approaches were assessed through data extraction and Stata 18 SE statistical analysis. Results: Of the 36 trials, 18/36 (50.0%) reported use of specific retention strategies, while 1/36 (2.8%) of the trials documented recruitment strategies for under‐represented groups. Diversity goals were also unreported in recruitment processes. Most trials (63.9%) received industry funding, and therapeutic intervention was the most common treatment type (97.2%). Limitations: Only articles from 2018 to 2023 were analyzed, limiting the finding generalizability over broader timeframes. Conclusion: This study reveals significant gaps in recruitment/retention strategies within HS trials, which is important for enhancing result relevance and inclusivity, particularly among historically marginalized populations. Implementing specific approaches and innovative methods is critical for improving HS treatment efficacy and reducing health inequities.
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Open AccessExamining Recruitment and Retention Strategies in Hidradenitis Suppurativa Clinical Trials: A Cross‐Sectional Study
Background: To ensure equitable and successful treatment outcomes for hidradenitis suppurativa (HS), the recruitment and retention of diverse participants in clinical trials is critical. However, current approaches may neglect under‐represented populations, potentially limiting the result application. Objective: This study aimed to evaluate existing recruitment and retention strategies in HS trials, identifying gaps and proposing methods to improve inclusivity and participant retention. Methods: We conducted a cross‐sectional analysis of 36 HS clinical trials from January 2018 to December 2023, following PRISMA guidelines. Trial characteristics and specific recruitment/retention approaches were assessed through data extraction and Stata 18 SE statistical analysis. Results: Of the 36 trials, 18/36 (50.0%) reported use of specific retention strategies, while 1/36 (2.8%) of the trials documented recruitment strategies for under‐represented groups. Diversity goals were also unreported in recruitment processes. Most trials (63.9%) received industry funding, and therapeutic intervention was the most common treatment type (97.2%). Limitations: Only articles from 2018 to 2023 were analyzed, limiting the finding generalizability over broader timeframes. Conclusion: This study reveals significant gaps in recruitment/retention strategies within HS trials, which is important for enhancing result relevance and inclusivity, particularly among historically marginalized populations. Implementing specific approaches and innovative methods is critical for improving HS treatment efficacy and reducing health inequities.
- Open Access
- 26 November 2024
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-9
Recruitment and Retention Strategies for Historically Marginalized Populations in Colorectal Cancer Trials: A Cross-Sectional Analysis Using Systematic Review Methods
Purpose Colorectal cancer (CRC), a leading cause of cancer mortality, disproportionately impacts historically marginalized populations due to persistent health inequities. Effective recruitment and retention strategies are crucial to improving the representation of these populations in clinical trials. This study aims to evaluate the use of recruitment and retention strategies in CRC clinical trials, their impact on participant diversity, and the presence of diversity recruitment goals and ethical considerations. Methods We conducted a cross-sectional analysis of CRC treatment trials following PRISMA guidelines. Eligible studies were assessed for recruitment and retention strategies, diversity recruitment goals, and ethical considerations. Data were extracted in duplicate, ensuring masked and independent evaluations. Results Of the 2563 records identified, 55 studies met the inclusion criteria. Most trials (83.6%) focused on therapeutic interventions, and government funding was the most common (38.2%). Only three studies (5.5%) reported strategies to recruit historically marginalized populations, and 54 studies (98.2%) lacked diversity recruitment goals. None of the trials discussed ethical considerations related to diverse recruitment. Conclusion This study highlights significant gaps in recruitment and retention strategies for historically marginalized populations in CRC clinical trials. Few studies implement strategies to address these disparities which affect the diversity of the trial population, underscoring the need for targeted efforts to improve trial inclusivity. Addressing these gaps is critical to ensuring more equitable and representative outcomes in CRC research.
- 26 November 2024
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-9
Open AccessRecruitment and Retention Strategies for Historically Marginalized Populations in Colorectal Cancer Trials: A Cross-Sectional Analysis Using Systematic Review Methods
Purpose Colorectal cancer (CRC), a leading cause of cancer mortality, disproportionately impacts historically marginalized populations due to persistent health inequities. Effective recruitment and retention strategies are crucial to improving the representation of these populations in clinical trials. This study aims to evaluate the use of recruitment and retention strategies in CRC clinical trials, their impact on participant diversity, and the presence of diversity recruitment goals and ethical considerations. Methods We conducted a cross-sectional analysis of CRC treatment trials following PRISMA guidelines. Eligible studies were assessed for recruitment and retention strategies, diversity recruitment goals, and ethical considerations. Data were extracted in duplicate, ensuring masked and independent evaluations. Results Of the 2563 records identified, 55 studies met the inclusion criteria. Most trials (83.6%) focused on therapeutic interventions, and government funding was the most common (38.2%). Only three studies (5.5%) reported strategies to recruit historically marginalized populations, and 54 studies (98.2%) lacked diversity recruitment goals. None of the trials discussed ethical considerations related to diverse recruitment. Conclusion This study highlights significant gaps in recruitment and retention strategies for historically marginalized populations in CRC clinical trials. Few studies implement strategies to address these disparities which affect the diversity of the trial population, underscoring the need for targeted efforts to improve trial inclusivity. Addressing these gaps is critical to ensuring more equitable and representative outcomes in CRC research.
- 25 November 2022
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 30 (2) , 100-107
Assessing the Reporting and Frequency of Harms in Systematic Reviews Focused on Minimally Invasive Hysterectomies: A Cross-sectional Analysis
- 25 November 2022
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 30 (2) , 100-107
Assessing the Reporting and Frequency of Harms in Systematic Reviews Focused on Minimally Invasive Hysterectomies: A Cross-sectional Analysis